KEY FEATURES
| Full Name | Mitogen Activated Protein Kinase 14 |
|---|---|
| Synonym | CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; P38; Mitogen-activated protein kinase p38 alpha; Cytokine suppressive anti-inflammatory drug-binding protein |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human MAPK14 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human MAPK14. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human MAPK14 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human MAPK14, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human MAPK14. You can calculate the concentration of Human MAPK14 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human MAPK14 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.48 | 1.17 | 3.58 | 0.49 | 1.18 | 3.87 |
| Standard deviation | 0.03 | 0.06 | 0.17 | 0.02 | 0.06 | 0.2 |
| CV(%) | 5.65 | 5.48 | 4.75 | 5.04 | 4.86 | 5.05 |
RECOVERY
The recovery of Human MAPK14 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 94-109 | 101 |
| EDTA plasma (n=8) | 93-109 | 100 |
| Cell culture media (n=8) | 89-102 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human MAPK14 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with MRP ELISA Kits
| MAPKAPK2 ELISA Kit | publications with MRP and MAPKAPK2 |
| MAP2K6 ELISA Kit | publications with MRP and MAP2K6 |
| MAP2K3 ELISA Kit | publications with MRP and MAP2K3 |
| ATF2 ELISA Kit | publications with MRP and ATF2 |
| DUSP1 ELISA Kit | publications with MRP and DUSP1 |
| MEF2C ELISA Kit | publications with MRP and MEF2C |
| DUSP10 ELISA Kit | publications with MRP and DUSP10 |
| DUSP16 ELISA Kit | publications with MRP and DUSP16 |
| MEF2A ELISA Kit | publications with MRP and MEF2A |
Pathways associated with MRP ELISA Kit
| ADP Signalling Through P2Y Purinoceptor 1 Pathway | ADP Signalling Through P2Y Purinoceptor 1 Pathway |
| AGE/RAGE Pathway | AGE/RAGE Pathway |
| ATF-2 Transcription Factor Network Pathway | ATF-2 Transcription Factor Network Pathway |
| Activated TLR4 Signalling Pathway | Activated TLR4 Signalling Pathway |
| Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation Pathway | Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation Pathway |
| Activation Of The AP-1 Family Of Transcription Factors Pathway | Activation Of The AP-1 Family Of Transcription Factors Pathway |
| Adrenergic Signaling In Cardiomyocytes Pathway | Adrenergic Signaling In Cardiomyocytes Pathway |
| Amyotrophic Lateral Sclerosis (ALS) Pathway | Amyotrophic Lateral Sclerosis (ALS) Pathway |
Diseases associated with MRP ELISA Kit
| Neoplasms | publications with MRP and Neoplasms |
| Inflammation | publications with MRP and Inflammation |
| Necrosis | publications with MRP and Necrosis |
| Nervous System Diseases | publications with MRP and Nervous System Diseases |
| Heart Diseases | publications with MRP and Heart Diseases |
| Cell Transformation, Neoplastic | publications with MRP and Cell Transformation, Neoplastic |
| Myocardial Ischemia | publications with MRP and Myocardial Ischemia |
| Fibrosis | publications with MRP and Fibrosis |
| Lung Neoplasms | publications with MRP and Lung Neoplasms |
| Adenocarcinoma | publications with MRP and Adenocarcinoma |
Organs/Tissues associated with MRP ELISA Kit
| Blood | publications with MRP and Blood |
| Muscle | publications with MRP and Muscle |
| Heart | publications with MRP and Heart |
| Lung | publications with MRP and Lung |
| Bone | publications with MRP and Bone |
| Liver | publications with MRP and Liver |
| Brain | publications with MRP and Brain |
| Vascular | publications with MRP and Vascular |
| Intestine | publications with MRP and Intestine |
| Kidney | publications with MRP and Kidney |